Medical Condition News

RSS

Arrayit announces collaboration with European Space Agency for mission-critical contribution

Arrayit Corporation (OTCBB: ARYC), a proprietary life sciences technology leader, announces a collaboration with the European Space Agency.

15 Oct 2009

MDS secures international cooperation to help Canadian teenager with malignant blood disorder

The Myelodysplastic Syndromes (MDS) Foundation says a wide range of international cooperation has been secured to help 18-year-old Wes Laporte of Ontario get treatment for a life-threatening condition in the US.

15 Oct 2009

Olympic gold medal winner Lisa Leslie and Covidien launch new liver cancer education program

Four-time Olympic gold medal winner and three-time WNBA Most Valuable Player Lisa Leslie is teaming with Covidien, a leading global provider of healthcare products, to launch an educational program and Web site, www.MyLiverCancerOptions.com, that provide information to help patients and their families understand the treatment options available to manage liver cancer.

15 Oct 2009

NFL, NDC launch 'Fuel Up to Play 60' to tackle childhood obesity

The NFL and National Dairy Council (NDC) today launch Fuel Up to Play 60, a new initiative aimed at tackling childhood obesity by giving youth a voice in changing the school nutrition and physical activity environment. The program will reach 36 million youth in 60,000 elementary, middle and high schools during the 2009/2010 school year.

15 Oct 2009

Soligenix commences enrollment in its Phase 3 Orbec clinical trial for acute GI GVHD

Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has initiated enrollment in its confirmatory Phase 3 randomized, double-blind, placebo-controlled, multicenter clinical trial evaluating orBec(®) for the treatment of acute gastrointestinal Graft-versus-Host disease (GI GVHD).

15 Oct 2009

Prometheus Laboratories introduces three new cancer diagnostic products

Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the nationwide commercial launch of three new cancer diagnostic products: ProOnc TumorSource Dx, ProOnc Squamous Dx and ProOnc Mesothelioma Dx. Each of these tests is based on recently developed, highly sensitive microRNA technology.

15 Oct 2009

Breathe Right "Extra" to help consumers sleep better at night

While many of us will never know the feeling of playing in a professional football game, we all should know the feeling of getting a good night's sleep. However, many adults suffer from night-time congestion, a good night's sleep can be as elusive as a speedy running back - until now.

15 Oct 2009

Inspire to present its denufosol tetrasodium cystic fibrosis program data at the 23rd NACFC

Inspire Pharmaceuticals, Inc. announced today Inspire scientists and collaborators will present data from the denufosol tetrasodium cystic fibrosis (CF) program in a poster presentation at the 23rd Annual North American Cystic Fibrosis Conference (NACFC) October 15 - 17, 2009 in Minneapolis, MN.

15 Oct 2009

New range of foods from marine animals and plants to help fight human diseases

Milk drinks that lower blood pressure, meat products that reduce the risk of heart disease, chocolate that calms you down and a new range of foods that can fight obesity can be created from marine animals and plants. Japan already has several product ranges on the shelves and research programmes are underway all over the world to create more.

15 Oct 2009

Managing Myeloma launches educational activities for multidisciplinary professionals

Managing Myeloma (www.ManagingMyeloma.com), an accredited educational initiative for multidisciplinary professionals, announces the launch of a series of regional continuing education activities to be held through October and November in five western states.

15 Oct 2009

Sangretech Biomedical signs amended license agreement with Bostwick Laboratories

Sangretech Biomedical LLC, a developer of dendritic cell therapies for cancer and infectious diseases, today announced it has executed an amended and restated license agreement with Bostwick Laboratories, Inc. providing Bostwick Scientific, the research division of Bostwick Laboratories, with exclusive rights to Sangretech’s dendritic cell technology in certain territories.

15 Oct 2009

Managing Myeloma website offers scholarship for attending the December 2009 American Society of Hematology Annual Meeting

Managing Myeloma (www.ManagingMyeloma.com), an accredited multi-supported educational website for multidisciplinary professionals, announces the opportunity for fellows in oncology to win a scholarship to attend the December 2009 American Society of Hematology Annual Meeting in New Orleans, Louisiana. The scholarship includes registration fees, airfare, hotel accommodations, and a per diem for meals.

15 Oct 2009

Positive results from Protalix BioTherapeutics Phase III UPLYSO clinical trial

Protalix BioTherapeutics, Inc., announced today positive top-line results from the Company's pivotal Phase III clinical trial of UPLYSO (taliglucerase alfa, previously referred to as prGCD) in treatment naive patients diagnosed with Gaucher disease.

15 Oct 2009

ADI and CeTeCancer collaborate for research project

Radient Pharmaceuticals Corporation, a US-based pharmaceutical company, announced today it has entered into a collaboration agreement through its wholly owned subsidiary AMDL Diagnostics, Inc. (ADI) with CeTeCancer -- a Chilean-based research laboratory -- to validate the effectiveness of Radient Pharmaceuticals' Onko-Sure™ in vitro diagnostic (IVD) cancer test as an early detection and prevention test for lung cancer.

15 Oct 2009

EP Global Communications to co-produce World Congress & Exposition on Disabilities conference

Some companies just don't get the attention and recognition that other more popular corporations do. But it seems that may all be changing as a growing number of people are seeking companies which perform services that affect the greater good of society.

15 Oct 2009

Vegetable lamb plant: New treatment for osteoporosis

The "vegetable lamb" plant - once believed to bear fruit that ripened into a living baby sheep - produces substances that show promise in laboratory experiments as new treatments for osteoporosis, the bone-thinning disease. That's the conclusion of a new study in ACS' monthly Journal of Natural Products.

15 Oct 2009

Delays contribute to unnecessary ER visits and additional imaging services in symptomatic gallstone treatment

Getting patients to the operating room more quickly could cut by half the amount paid for hospital treatment of painful gallstones, researchers reported today at the 2009 Clinical Congress of the American College of Surgeons.

15 Oct 2009

A study on development of deaf children fitted with a Cochlear Implant

A multidisciplinary group at Malaga University, headed by Ignacio Moreno-Torres, is collecting information on the milestones that mark the development of deaf children fitted with a Cochlear Implant (CI) and studying to what extent the social and family environment affects this development. This research is funded with 101,000 euro by the Andalusian Regional Ministry of Innovation.

15 Oct 2009

Negative symptoms represent an attractive target for drug development

A half-day workshop on issues in the design of clinical trials to evaluate treatments for negative symptoms of schizophrenia, chaired by Stephen Marder, MD, UCLA Department of Psychiatry and David Daniel, M.D., United BioSource Corporation was held 5 October 2009, as part of the International Society for CNS Clinical Trials and Methodology (ISCTM) Autumn Conference in San Diego, CA.

15 Oct 2009

National Biological to market Quantel's 308 Excimer System in the U.S.

Quantel SA (Euronext: QUA), a leading manufacturer of solid state lasers, announced today that it has entered into a Distribution Agreement with National Biological, a leading researcher and developer of light-based systems for medical and cosmetic treatments, for Quantel's 308 Excimer System for monochromatic UVB treatment of psoriasis and vitiligo in the United States.

15 Oct 2009

Medical Condition News

Arrayit announces collaboration with European Space Agency for mission-critical contribution

MDS secures international cooperation to help Canadian teenager with malignant blood disorder

Olympic gold medal winner Lisa Leslie and Covidien launch new liver cancer education program

NFL, NDC launch 'Fuel Up to Play 60' to tackle childhood obesity

Soligenix commences enrollment in its Phase 3 Orbec clinical trial for acute GI GVHD

Prometheus Laboratories introduces three new cancer diagnostic products

Breathe Right "Extra" to help consumers sleep better at night

Inspire to present its denufosol tetrasodium cystic fibrosis program data at the 23rd NACFC

New range of foods from marine animals and plants to help fight human diseases

Managing Myeloma launches educational activities for multidisciplinary professionals

Sangretech Biomedical signs amended license agreement with Bostwick Laboratories

Managing Myeloma website offers scholarship for attending the December 2009 American Society of Hematology Annual Meeting

Positive results from Protalix BioTherapeutics Phase III UPLYSO clinical trial

ADI and CeTeCancer collaborate for research project

EP Global Communications to co-produce World Congress & Exposition on Disabilities conference

Vegetable lamb plant: New treatment for osteoporosis

Delays contribute to unnecessary ER visits and additional imaging services in symptomatic gallstone treatment

A study on development of deaf children fitted with a Cochlear Implant

Negative symptoms represent an attractive target for drug development

National Biological to market Quantel's 308 Excimer System in the U.S.

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Latest News